Essential Therapeutics (ETRX) formerly Microcide (MCDE Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Essential Therapeutics (ETRX) formerly Microcide (MCDE

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (392)	6/10/2002 7:39:14 PM
From: SemiBull	Read Replies (1) of 415

Essential Therapeutics to shut programs, cut jobs WALTHAM, Mass., June 10 (Reuters) - Biotechnology firm Essential Therapeutics Inc. (NasdaqNM:ETRX - News) on Monday said it is eliminating several early-stage drug development programs and cutting related jobs in order to focus on mid-stage trials of drugs currently in its research pipeline. The programs being cut employ about 80 people, the company said. It did not clarify whether all 80 positions will be eliminated. Essential Therapeutics said it is allocating funds for three new Phase II clinical trials that will focus on the company's lead compound, ETRX-101. The company also said it is putting more resources into developing several antibiotic and antifungal compounds that are already in its pipeline.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next